Dhyan Chandra Selected Research

Dhyan Chandra Research Topics

Disease

27	Neoplasms (Cancer) 01/2022 - 07/2003
11	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 05/2002
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 05/2015
4	Breast Neoplasms (Breast Cancer) 09/2015 - 08/2004
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2018
2	Carcinogenesis 01/2014 - 12/2013
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	7 Hereditary Prostate Cancer 01/2019
1	Adenocarcinoma 01/2017
1	Embryonal Carcinoma 01/2014
1	Colonic Neoplasms (Colon Cancer) 09/2013
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2013
1	Pathologic Processes 08/2010
1	Starvation 03/2005

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
5	Mitochondrial DNA (mtDNA)IBA 01/2022 - 06/2011
5	CaspasesIBA 01/2019 - 08/2011
4	EnzymesIBA 01/2020 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 08/2010
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 05/2015
2	Cytochromes c (Cytochrome c)IBA 01/2020 - 01/2019
2	Apoptosomes (Apoptosome)IBA 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2013
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2016 - 05/2015
2	AcidsIBA 01/2014 - 05/2002
2	Transcription Factors (Transcription Factor)IBA 01/2014 - 01/2013
2	ResveratrolIBA 09/2013 - 08/2011
2	Caspase 3 (Caspase-3)IBA 11/2012 - 12/2011
2	Caspase 8 (Caspase-8)IBA 11/2012 - 08/2004
2	Messenger RNA (mRNA)IBA 05/2009 - 05/2002
2	Etoposide (VP 16)FDA LinkGeneric 03/2005 - 08/2004
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 09/2004 - 07/2003
1	ApoferritinsIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2020
1	NucleotidesIBA 01/2020
1	ImmunosorbentsIBA 11/2019
1	Interleukin-8 (Interleukin 8)IBA 11/2019
1	ThapsigarginIBA 11/2019
1	apicidinIBA 11/2019
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 11/2019
1	Histone Deacetylase InhibitorsIBA 11/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	Photosensitizing Agents (Photosensitizers)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	TriterpenesIBA 01/2018
1	nimbolideIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Flavin-Adenine Dinucleotide (FAD)IBA 01/2017
1	LipidsIBA 01/2017
1	NAD (NADH)IBA 01/2017
1	Tryptophan (L-Tryptophan)FDA Link 01/2017
1	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2016
1	LimoninsIBA 01/2016
1	AmberIBA 09/2015
1	ORALIT (ORS)IBA 09/2015
1	Estrogen ReceptorsIBA 09/2015
1	Androgen Receptors (Androgen Receptor)IBA 01/2014
1	3-methyladenineIBA 09/2013
1	Initiator CaspasesIBA 11/2012
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 11/2012
1	CurcuminIBA 12/2011
1	AntioxidantsIBA 08/2010
1	Nanog Homeobox ProteinIBA 05/2009
1	Small Interfering RNA (siRNA)IBA 05/2009
1	Superoxide DismutaseIBA 03/2005
1	A-Form DNA (A-DNA)IBA 03/2005
1	AndrogensIBA 09/2004

Therapy/Procedure

7	Therapeutics 01/2017 - 03/2005
2	Radiotherapy 08/2014 - 05/2014
1	Lasers (Laser) 01/2019
1	Photochemotherapy (Photodynamic Therapy) 01/2019
1	Castration 01/2017
1	Aftercare (After-Treatment) 01/2017
1	Immunotherapy 08/2014
1	Traditional Medicine (Folk Remedies) 08/2014
1	Drug Therapy (Chemotherapy) 05/2014